No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong James Selkirk?

Dr. James K. Selkirk

Deputy Director


Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.


Background Information

Employment History

Deputy Director, National Center for Toxicogenomics

National Institute of Environmental Health Sciences

Deputy Director

National Center for Toxicogenomics

Lab Chief, Mechanisms of Chemical Carcinogenesis

Oak Ridge National Laboratory



Web References (11 Total References)

Data Explosion: Bringing Order to Chaos with Bioinformatics [cached]

According to James Selkirk, deputy director of the NCT, this "ToxChip" is being designed in cooperation with the NIEHS-funded Toxicogenomics Research Consortium, a group of five academic research centers plus the Microarray Center. The intention, he says, is to produce a chip containing a large number of genes thought to be relevant to the toxicity of environmental agents. "This should be something that is of wide interest to the microarray profiling public," Selkirk says.

EHP 111-3, 2003: Not-So-Superfund: Growing Needs vs. Declining Dollars [cached]

But integrating SNP data with toxicogenomics is a long way off, says NCT deputy director James Selkirk. "When the SNPs are identified in known genes, we can look to see how they affect specific genomic pathways," he says.

Phenotypic anchoring, says Selkirk, is a technique that couples the unique gene expression patterns induced by chemical exposures to visible evidence of harm. In this fashion, the gene expression patterns provide chemical-specific signatures for toxicological pathways and effects.
Ideally, the signatures should relate to expression profiles obtained at multiple dose levels, Selkirk says.
According to Selkirk, NCT scientists are using genomic and proteomic tools to identify the biochemical pathways corresponding to therapeutic and toxic doses. "We want to study both pathways so we know where and when they diverge, and how toxicity is manifested," Selkirk says.

Past Gordon Research Conference Proposals [cached]

James K. Selkirk, Deputy Director, National Center for Toxicogenomics, NIEHS

World Trade Group - Summit Club [cached]

World Trade's Craig Eason spoke to Dr James Selkirk of the Institute of Environmental Health Science's National Centre for Toxicogenomics about the developments in this field of research, the development of a public knowledge database and the implications for understanding disease.

Dr James Selkirk
Craig Eason met with Thomas Power, a self-made entrepreneur, at the Institute of Director's office in Pall Mall to talk about what he sees as a new world of social capitalism. >>read article (17/03/03) Dr James Selkirk

ISSX Drug Metabolism-Providence [cached]

Chair: James K. Selkirk, National Institute of Environmental Health Services, Research Triangle Park, NC, USA

Similar Profiles

Other People with this Name

Other people with the name Selkirk

Michelle Selkirk
Canandaigua Medical Group

Colleen Selkirk
City of Burlington

Michael Selkirk
Gibson , Dunn & Crutcher LLP

Pam Selkirk
Fleming College

Sheri Selkirk
Brownell Travel Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory